Schedule 13G ownership disclosure
CELLCEUTIX CORP COM
Security class unavailable · CUSIP: 15115V101
Event date: 2021-04-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-21-024168
- Form type
- SC 13G
- Filer
- Innovation Pharmaceuticals Inc.
- CIK
- CIK 1355250
- Filed
- May 03, 2021
- Reporting period
- Apr 19, 2021
- Description
- Schedule 13G beneficial ownership